Abstract
Ionizing radiation is a well known risk factor of thyroid cancer development, but the mechanism of radiation induced carcinogenesis is not clear. The RETPTC oncogene, an activated form of the RET proto-oncogene, is frequently observed in papillary thyroid carcinoma (PTC); RETPTC1, -2 and -3 are known to be the three major forms. High frequencies of RETPTC rearrangements have been observed in radiation-associated PTC, such as those appearing post-Chernobyl or post-radiotherapy, but the rearrangement types differ between these two populations. We investigated whether a specific type of RETPTC rearrangement was induced by X-rays in vivo and in vitro. In human normal thyroid tissues transplanted in scid mice, the RETPTC1 rearrangement was predominantly detected throughout the observation period (up to 60 days) after X-ray exposure of 50 Gy. On the other hand, RETPTC3 was detected only 7 days after X-irradiation, and no transcript of RETPTC2 was detected. These results are supported by the results of an in vitro study. The RETPTC1 rearrangement was preferentially induced in a dose-dependent manner by X-rays within a high dose range (10, 50 and 100 Gy) in four cell lines. On the other hand, RETPTC3 was induced at a much lower frequency, and no induction of RETPTC2 was observed. These results suggest that the preferential induction of the RETPTC1 rearrangement may play an important role in the early steps of thyroid carcinogenesis induced by acute X-irradiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G and Pierotti MA. . 1994 Cancer Res. 54: 2979–2985.
Bongarzone I, Butti MG, Fugazzola L, Pacini F, Pinchera A, Vorontsova TV, Demidchik EP and Pierotti MA. . 1997 Genomics 42: 252–259.
Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G and Pierotti MA. . 1993 Mol. Cell. Biol. 13: 358–366.
Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M and Suarez HG. . 1997 Oncogene 15: 1263–1273.
Chan LC, Karhi KK, Rayter SI, Heistercamp N, Eridani S, Powless R, Lawler SD, Groffen J, Foulkes JG, Greaves MF and Weidenmann LM. . 1987 Nature 325: 635–637.
de Klein A, van Kessel AD, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heistercamp N, Groffen J and Stephenson JR. . 1982 Nature 300: 765–767.
Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP, Pacini F and Pierotti MA. . 1995 Cancer Res. 55: 5617–5620.
Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A and Vecchio G. . 1990 Cell 60: 557–663.
Hancock SL, McDougall IR and Constine LS. . 1995 Int. J. Radiat. Oncol. Biol. Physics 31: 1165–1170.
Heisterkamp N, Knoppel E and Groffen J. . 1988 Nucleic Acids Res. 16: 10069–10081.
Ishizaka Y, Ushijima T, Sugimura T and Nagao M. . 1990 Biochem. Biophys. Res. Comm. 168: 402–408.
Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N and Akiyama M. . 1993a Cancer Res. 53: 2940–2943.
Ito T, Seyama T, Iwamoto KS, Mizuno T, Tronko ND, Komissarenko IV, Cherstovoy ED, Satow Y, Takeichi N, Dohi K and Akiyama M. . 1994 Lancet 344: 259.
Ito T, Seyama T, Mizuno T, Hayashi T, Iwamoto KS, Dohi K, Nakamura N and Akiyama M. . 1993b Jpn. J. Cancer Res. 84: 105–109.
Kitamura Y, Minobe K, Nakata T, Shimizu K, Tanaka S, Fujimori M, Yokoyama S, Ito K, Onda M and Emi M. . 1999 J. Hum. Genet. 44: 96–102.
Klugbauer S, Lengfelder E, Demidchik EP and Rabes HM. . 1995 Oncogene 11: 2459–2467.
Learoyd DL, Messina M, Zedenius J, Guinea AI, Delbridge LW and Robinson BG. . 1998 J. Clin. Endocrinol. Metab. 83: 3631–3635.
Mayr B, Potter E, Goretzki P, Ruschoff J, Dietmaier W, Hoang-Vu C, Dralle H and Brabant G. . 1998 Br. J. Cancer 77: 903–906.
Minoletti F, Butti MG, Coronelli S, Miozzo M, Sozzi G, Pilotti S, Tunnacliffe A, Pierotti MA and Bongarzone I. . 1994 Genes Chrom. Cancer 11: 51–57.
Mizuno T, Kyoizumi S, Suzuki T, Iwamoto KS and Seyama T. . 1997 Oncogene 15: 1455–1460.
Morris CM, Heisterkamp N, Groffen J and Fitzgerald PH. . 1990 Blood 78: 1078–1084.
Motomura T, Nikiforov YE, Namba H, Ashizawa K, Nagataki S, Yamashita S and Fagin JA. . 1998 Thyroid 8: 485–489.
Murnane JP. . 1996 Mutat. Res. 367: 11–23.
Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H and Fagin JA. . 1997 Cancer Res. 57: 1690–1694.
Pisarchik AV, Ermak G, Demidchik EP, Mikhalevich LS, Kartel NA and Figge J. . 1998 Thyroid 8: 1003–1008.
Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Nonaka H, Thompson DE, Soda M and Mabuchi K. . 1994 Radiat. Res. 137S: 68–97.
Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA and Boice Jr JD. . 1995 Radiat. Res. 141: 259–277.
Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A. . 1994 Oncogene 9: 509–516.
Smanik PA, Furminger TL, Mazzaferri E and Jhiang SM. . 1995 Hum. Mol. Gen. 4: 2313–2318.
Smida J, Salassidis K, Hieber L, Zitzelsberger H, Kellerer AM, Demidchik EP, Negele T, Spelsberg F, Lengfelder E, Werner M and Bauchinger M. . 1999 Int. J. Cancer 80: 32–38.
Sugg SL, Zheng L, Rosen IB, Freeman JL, Ezzat S and Asa SL. . 1996 J. Clin. Endocrinol. Metab. 81: 3360–3365.
Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S and Preston DL. . 1994 Radiat. Res. 137S: 17–67.
Tucker MA, Jones PH, Boice Jr JD, Robison LL, Stone BJ, Stovall M, Jenkin RD, Lubin JH, Baum ES, Siegel SE, Meadows AT, Hoover RN and Fraumeni Jr JF. . 1991 Cancer Res. 51: 2885–2888.
Williams D. . 1994 Nature 371: 556.
Acknowledgements
The authors are grateful to Shiho Fujii-Yano, Naohiro Tsuyama and Chiyoe Saito for technical support. This publication is based on research performed at the Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan. RERF is a private nonprofit foundation funded equally by the Japanese Ministry of Health and Welfare and the US Department of Energy through the National Academy of Sciences.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mizuno, T., Iwamoto, K., Kyoizumi, S. et al. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation . Oncogene 19, 438–443 (2000). https://doi.org/10.1038/sj.onc.1203343
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203343
Keywords
This article is cited by
-
Pathogenesis of cancers derived from thyroid follicular cells
Nature Reviews Cancer (2023)
-
N-Acetyl-l-cysteine protects thyroid cells against DNA damage induced by external and internal irradiation
Radiation and Environmental Biophysics (2017)
-
Follicular cell-derived thyroid cancer
Nature Reviews Disease Primers (2015)
-
Molecular genetics and diagnosis of thyroid cancer
Nature Reviews Endocrinology (2011)